St. Louis Trust Co held its position in shares of Express Scripts Holding Company (NASDAQ:ESRX) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,378 shares of the company’s stock at the end of the first quarter. St. Louis Trust Co’s holdings in Express Scripts Holding Company were worth $223,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Dubuque Bank & Trust Co. boosted its stake in Express Scripts Holding Company by 53.1% in the first quarter. Dubuque Bank & Trust Co. now owns 1,753 shares of the company’s stock worth $116,000 after buying an additional 608 shares in the last quarter. Capital Analysts LLC boosted its stake in Express Scripts Holding Company by 15.2% in the fourth quarter. Capital Analysts LLC now owns 1,777 shares of the company’s stock worth $122,000 after buying an additional 235 shares in the last quarter. Independent Advisor Alliance bought a new stake in Express Scripts Holding Company during the fourth quarter worth approximately $124,000. Pinnacle Bank bought a new stake in Express Scripts Holding Company during the first quarter worth approximately $143,000. Finally, SRB Corp raised its stake in shares of Express Scripts Holding Company by 6.4% in the third quarter. SRB Corp now owns 2,038 shares of the company’s stock worth $144,000 after buying an additional 123 shares during the last quarter. Institutional investors and hedge funds own 89.43% of the company’s stock.

Institutional Ownership by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)

Shares of Express Scripts Holding Company (ESRX) traded down 0.13% during midday trading on Friday, hitting $63.01. The stock had a trading volume of 9,298,255 shares. The stock has a 50 day moving average price of $60.94 and a 200-day moving average price of $66.89. Express Scripts Holding Company has a 52 week low of $57.80 and a 52 week high of $80.02. The stock has a market capitalization of $37.40 billion, a price-to-earnings ratio of 11.42 and a beta of 0.94.

Express Scripts Holding Company (NASDAQ:ESRX) last issued its quarterly earnings results on Monday, April 24th. The company reported $1.33 EPS for the quarter, beating the Zacks’ consensus estimate of $1.32 by $0.01. The business had revenue of $24.65 billion for the quarter, compared to analysts’ expectations of $24.95 billion. Express Scripts Holding Company had a net margin of 3.42% and a return on equity of 25.64%. The business’s quarterly revenue was down .6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.22 earnings per share. Equities research analysts anticipate that Express Scripts Holding Company will post $6.97 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “St. Louis Trust Co Holds Stake in Express Scripts Holding Company (ESRX)” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another site, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/06/16/st-louis-trust-co-maintains-position-in-express-scripts-holding-company-esrx-updated-updated.html.

ESRX has been the topic of a number of research analyst reports. Credit Suisse Group reissued a “buy” rating and issued a $85.00 price target on shares of Express Scripts Holding Company in a research note on Thursday, February 16th. Zacks Investment Research lowered Express Scripts Holding Company from a “buy” rating to a “hold” rating in a research note on Thursday, February 16th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $88.00 price objective on shares of Express Scripts Holding Company in a research note on Friday, February 17th. Vetr upgraded Express Scripts Holding Company from a “hold” rating to a “buy” rating and set a $79.36 target price on the stock in a report on Monday, February 27th. Finally, Leerink Swann upgraded Express Scripts Holding Company to a “positive” rating in a report on Tuesday, March 7th. Three equities research analysts have rated the stock with a sell rating, eleven have given a hold rating, five have given a buy rating and one has given a strong buy rating to the company. Express Scripts Holding Company currently has a consensus rating of “Hold” and an average price target of $71.95.

In related news, VP Phyllis S. Anderson sold 1,100 shares of the company’s stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $60.08, for a total value of $66,088.00. Following the sale, the vice president now owns 11,108 shares in the company, valued at approximately $667,368.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.68% of the stock is owned by corporate insiders.

Express Scripts Holding Company Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.